Figure 3From: Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15Distribution of the MA and BL tumors according to ER, HER2, GCDFP15 and AR immunostainings. Numbers of tumors in each subgroup are indicated. AR, androgen receptor; BL, basal-like; ER, estrogen receptor; HER2, Human Epidermal Growth Factor Receptor 2; MA, molecular apocrine.Back to article page